Compare HUMA & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUMA | EPM |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 158.2M |
| IPO Year | N/A | 1996 |
| Metric | HUMA | EPM |
|---|---|---|
| Price | $1.20 | $4.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $10.00 | $4.93 |
| AVG Volume (30 Days) | ★ 5.9M | 412.0K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | ★ 10.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $43,229,621.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $731.05 | N/A |
| P/E Ratio | ★ N/A | $92.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $3.19 |
| 52 Week High | $3.35 | $5.70 |
| Indicator | HUMA | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 65.70 |
| Support Level | $0.92 | $4.38 |
| Resistance Level | $1.26 | $4.63 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 70.45 | 64.86 |
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.